Alkami Technology (ALKT) Competitors

Doximity (NASDAQ:DOCS) and Alkami Technology (NASDAQ:ALKT) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

Do analysts rate DOCS or ALKT?

Doximity currently has a consensus price target of $62.89, suggesting a potential upside of 18.64%. Alkami Technology has a consensus price target of $39.88, suggesting a potential upside of 29.67%. Given Alkami Technology's stronger consensus rating and higher probable upside, analysts clearly believe Alkami Technology is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	0 Sell rating(s)	11 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.57
Alkami Technology	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has more risk & volatility, DOCS or ALKT?

Doximity has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, Alkami Technology has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in DOCS or ALKT?

87.2% of Doximity shares are held by institutional investors. Comparatively, 55.0% of Alkami Technology shares are held by institutional investors. 37.4% of Doximity shares are held by company insiders. Comparatively, 18.1% of Alkami Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has higher earnings & valuation, DOCS or ALKT?

Doximity has higher revenue and earnings than Alkami Technology. Alkami Technology is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$570.40M	17.35	$147.58M	$1.11	47.76
Alkami Technology	$355.56M	8.91	-$62.91M	-$0.38	-80.92

Does the MarketBeat Community prefer DOCS or ALKT?

Doximity received 12 more outperform votes than Alkami Technology when rated by MarketBeat users. However, 63.33% of users gave Alkami Technology an outperform vote while only 40.35% of users gave Doximity an outperform vote.

Company	Underperform	Outperform
Doximity	Outperform Votes 69 40.35%	Underperform Votes 102 59.65%
Alkami Technology	Outperform Votes 57 63.33%	Underperform Votes 33 36.67%

Is DOCS or ALKT more profitable?

Doximity has a net margin of 36.60% compared to Alkami Technology's net margin of -14.55%. Doximity's return on equity of 21.75% beat Alkami Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	36.60%	21.75%	18.64%
Alkami Technology	-14.55%	-11.31%	-9.15%

Does the media prefer DOCS or ALKT?

In the previous week, Doximity had 41 more articles in the media than Alkami Technology. MarketBeat recorded 55 mentions for Doximity and 14 mentions for Alkami Technology. Alkami Technology's average media sentiment score of 1.50 beat Doximity's score of 0.54 indicating that Alkami Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	19 Very Positive mention(s)	3 Positive mention(s)	14 Neutral mention(s)	7 Negative mention(s)	0 Very Negative mention(s)	Positive
Alkami Technology	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Alkami Technology on 15 of the 19 factors compared between the two stocks.